Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire-Reference-Cited by-同舟云学术

Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire

Published:2014-09 Issue:9 Volume:20 Page:1349-1355
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Damaj Gandhi,Mohty Mohammad,Robin Marie,Michallet Mauricette,Chevallier Patrice,Beguin Yves,Nguyen Stephanie,Bories Pierre,Blaise Didier,Maillard Natacha,Rubio Marie Therese,Fegueux Nathalie,Cornillon Jerome,Clavert Aline,Huynh Anne,Adès Lionel,Thiébaut-Bertrand Anne,Hermine Olivier,Vigouroux Stephane,Fenaux Pierre,Duhamel Alain,Yakoub-Agha Ibrahim

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission;Martino;Bone Marrow Transplant,2008

2. Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS;de Witte;Blood,2001

3. Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan;Oran;Biol Blood Marrow Transplant,2007

4. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation;Yakoub-Agha;J Clin Oncol,2000

5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden;Warlick;Biol Blood Marrow Transplant,2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC);Bulletin du Cancer;2024-09

2. Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?;Blood;2024-07-25

3. Hematopoietic cell transplantation (HCT) in MDS patients of older age;Leukemia & Lymphoma;2024-02-05

4. Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation;Bone Marrow Transplantation;2022-04-22

5. Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study;Bone Marrow Transplantation;2022-02-02